Tue, October 3, 2023
Mon, October 2, 2023
Sun, October 1, 2023
Fri, September 29, 2023
Thu, September 28, 2023
Wed, September 27, 2023
Tue, September 26, 2023

Luke Sergott Maintained (TXG) at Buy with Decreased Target to $47 on, Sep 29th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-47-on-sep-29th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Luke Sergott of Barclays, Maintained "10x Genomics, Inc." (TXG) at Buy with Decreased Target from $66 to $47 on, Sep 29th, 2023.

Luke has made no other calls on TXG in the last 4 months.



There are 4 other peers that have a rating on TXG. Out of the 4 peers that are also analyzing TXG, 0 agree with Luke's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Luke


  • Kyle Mikson of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $70 on, Tuesday, September 19th, 2023
  • Tejas Savant of "Morgan Stanley" Reiterated at Buy and Held Target at $65 on, Monday, August 7th, 2023
  • Patrick Donnelly of "Citigroup" Maintained at Strong Buy with Increased Target to $75 on, Friday, August 4th, 2023
  • Matthew Sykes of "Goldman Sachs" Maintained at Strong Sell with Increased Target to $30 on, Thursday, July 13th, 2023

Publication Contributing Sources